Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NINTEDANIB vs NIRSEVIMAB-ALIP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NINTEDANIB vs NIRSEVIMAB-ALIP: Safety Overview

Metric NINTEDANIB NIRSEVIMAB-ALIP
Total FAERS Reports 26,243 783
Deaths Reported 5,822 32
Death Rate 22.2% 4.1%
Hospitalizations 9,433 281
Average Patient Age 70.7 yrs 3.3 yrs
% Female Patients 41.8% 46.3%
Marketing Status None Prescription